Why the study?
Does oral sildenafil prevent endothelial dysfunction induced by ischemia-reperfusion in healthy male volunteers?
Population
17 healthy male volunteers across two protocols.
Comparison
Oral sildenafil 50 mg administered 2 hours… vs Matching placebo administered 2 hours before…
Design
RCT, Randomized (crossover design), Double-blind
Follow-up
2 hours post-dose
Authors
Loading...
Supports testing sildenafil for cardioprotection in at-risk patients; extends prior observations to a human ischemia-reperfusion model.
Does oral sildenafil prevent endothelial dysfunction induced by ischemia-reperfusion in healthy male volunteers?
Oral sildenafil provides potent protection against ischemia-reperfusion-induced endothelial dysfunction in humans, an effect mediated by the opening of K(ATP) channels.
Gori et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: